Cargando…
Deleted in Liver Cancer 1 (DLC1) Utilizes a Novel Binding Site for Tensin2 PTB Domain Interaction and Is Required for Tumor-Suppressive Function
BACKGROUND: Deleted in liver cancer 1 (DLC1) is a Rho GTPase-activating protein (RhoGAP) frequently deleted and underexpressed in hepatocellular carcinoma (HCC) as well as in other cancers. Recent independent studies have shown interaction of DLC1 with members of the tensin focal adhesion protein fa...
Autores principales: | Chan, Lo-Kong, Ko, Frankie Chi Fat, Ng, Irene Oi-Lin, Yam, Judy Wai Ping |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680019/ https://www.ncbi.nlm.nih.gov/pubmed/19440389 http://dx.doi.org/10.1371/journal.pone.0005572 |
Ejemplares similares
-
Nuclear-Targeted Deleted in Liver Cancer 1 (DLC1) Is Less Efficient in Exerting Its Tumor Suppressive Activity Both In Vitro and In Vivo
por: Chan, Lo-Kong, et al.
Publicado: (2011) -
Deleted in Liver Cancer 1 (DLC1) Negatively Regulates Rho/ROCK/MLC Pathway in Hepatocellular Carcinoma
por: Wong, Carmen Chak-Lui, et al.
Publicado: (2008) -
Solution Structure of Tensin2 SH2 Domain and Its Phosphotyrosine-Independent Interaction with DLC-1
por: Dai, Kun, et al.
Publicado: (2011) -
Deletion of the Tensin2 SH2-PTB domain, but not the loss of its PTPase
activity, induces podocyte injury in FVB/N mouse strain
por: Sasaki, Hayato, et al.
Publicado: (2019) -
Integrin-Linked Kinase Overexpression and Its Oncogenic Role in Promoting Tumorigenicity of Hepatocellular Carcinoma
por: Chan, Jenny, et al.
Publicado: (2011)